Niagen Bioscience, Inc. (NAGE) Stock Total Returns

Growth of $10,000 chart

2021-04-21 to 2026-04-21
to
$
%
%
Loading chart…

Investment Performance

Final Value
$6,220
Total Return
-37.80%
CAGR
-9.06%
Dividends
$0.00
Yield on Cost
0.00%

Rolling Returns

1-Month (21 Trading Days)
Average+1.76%
Median-4.28%
Best+163.13%
Worst-34.60%
% of Windows Positive39.5%
1-Year (252 Trading Days)
Average+60.98%
Median-1.24%
Best+482.79%
Worst-83.58%
% of Windows Positive48.5%
3-Year (756 Trading Days)
Average+195.88%
Median+179.74%
Best+742.68%
Worst-74.54%
% of Windows Positive72.7%

Risk Metrics

Maximum Drawdown -88.71%
Average Drawdown -61.25%
Drawdown Duration 989 Trading Days
Sortino Ratio 0.39
Calmar Ratio -0.10
CVaR (5%) -9.15%

Yearly Returns

Year Percentage Abs. Return Dividends Taxes Trans. Costs
2026 partial -25.47% (-61.99% ann.) $2547.18 $0.00 $0.00 $0.00
2025 +19.77% +$1977.41 $0.00 $0.00 $0.00
2024 +271.33% +$27132.92 $0.00 $0.00 $0.00
2023 -14.88% $1488.13 $0.00 $0.00 $0.00
2022 -55.08% $5508.01 $0.00 $0.00 $0.00
2021 -22.08% $2208.33 $0.00 $0.00 $0.00
2020 +11.37% +$1136.88 $0.00 $0.00 $0.00
2019 +25.66% +$2565.61 $0.00 $0.00 $0.00
2018 -41.67% $4166.67 $0.00 $0.00 $0.00
2017 +77.64% +$7764.35 $0.00 $0.00 $0.00
2016 -9.56% $956.30 $0.00 $0.00 $0.00
2015 +38.64% +$3863.66 $0.00 $0.00 $0.00
2014 -42.11% $4210.53 $0.00 $0.00 $0.00
2013 +186.79% +$18679.37 $0.00 $0.00 $0.00
2012 -3.64% $363.69 $0.00 $0.00 $0.00
2011 -59.56% $5955.87 $0.00 $0.00 $0.00
2010 +209.09% +$20908.96 $0.00 $0.00 $0.00
2009 -62.39% $6239.30 $0.00 $0.00 $0.00
2008 partial -70.00% (-90.24% ann.) $7000.00 $0.00 $0.00 $0.00

Market Regimes

about
Regime Period Percentage Annual Abs. Return Dividends Taxes Trans. Costs
GFC / deleveraging / dollar shortage partial June 25, 2008 – March 9, 2009 -82.05% -91.29% $8205.13 $0.00 $0.00 $0.00
Policy-led rebound / euro-sovereign-crisis overlay March 10, 2009 – July 25, 2012 -6.41% -1.94% $641.05 $0.00 $0.00 $0.00
Secular stagnation / QE / low inflation / duration bull July 26, 2012 – February 19, 2020 +89.67% +8.83% +$8967.16 $0.00 $0.00 $0.00
Pandemic shock / liquidity crash February 20, 2020 – March 23, 2020 -37.75% -99.55% $3774.51 $0.00 $0.00 $0.00
Policy bazooka / monetary euphoria March 24, 2020 – November 6, 2020 +54.83% +102.06% +$5482.79 $0.00 $0.00 $0.00
Reopening reflation / fiscal boom / supply bottlenecks November 9, 2020 – November 29, 2021 -1.25% -1.18% $124.74 $0.00 $0.00 $0.00
Inflation shock / duration crash / aggressive tightening November 30, 2021 – November 9, 2022 -62.47% -64.68% $6247.35 $0.00 $0.00 $0.00
Disinflation rebound / AI-led narrow bull / higher-for-longer November 10, 2022 – September 17, 2024 +85.33% +39.49% +$8532.60 $0.00 $0.00 $0.00
Disinflationary easing / resilient growth / AI capex under oil-shock test partial September 18, 2024 – April 21, 2026 +33.52% +19.97% +$3352.10 $0.00 $0.00 $0.00

Dividend History

Date Per Share Yield %
Total 0 payments
No dividends recorded.

All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.

For each rolling window, returns are calculated at every possible starting point:

return = (value[i] ÷ value[i − windowSize] − 1) × 100

Windows
1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
Statistics
Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.

The series is segmented by calendar year:

return = (endValue ÷ startValue − 1) × 100

startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.

SABR

CAGR -15.39% Total -86.56% Final $1,344
2014-04-17 — 2026-04-21
BFC

CAGR 11.48% Total 1055.54% Final $115,554
2003-10-15 — 2026-04-21
IBOC

CAGR 11.82% Total 2970.33% Final $307,033
1995-08-30 — 2026-04-21